Vaccinations

COVID infections in pregnant women may affect newborn heart development --China study

Thu, 2024-10-24 10:06 — mike kraft

Maternal COVID infections may affect newborn heart development Ten percent of newborns in the COVID-19 group had abnormalities, compared with 4% in the control group. CIDRAP

Maternal COVID-19 infection during pregnancy may adversely affect the development of the newborn's heart, resulting in congenital heart defects (CHD), researchers suggested yesterday in Scientific Reports.

...

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Situation Report

Read more about COVID infections in pregnant women may affect newborn heart development --China study
Log in or register to post comments

CDC Recommends Second Dose of 2024-2025 COVID-19 Vaccine for Older People And Those Who are Moderately or Severely Immunocompromised

Thu, 2024-10-24 09:57 — mike kraft

CDC Recommends Second Dose of 2024-2025 COVID-19 Vaccine for People 65 Years and Older and for People Who are Moderately or Severely Immunocompromised Today, CDC Director Mandy Cohen endorsed the CDC Advisory Committee on Immunization Practices’ (AC CDC CDC Newsroom

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Situation Report

Repeated COVID vaccinations found to enhance mucosal immunity in the nose against the virus

Wed, 2024-10-23 19:27 — mike kraft

Repeated COVID vaccinations found to enhance mucosal immunity against the virus During the COVID pandemic, many of us received multiple mRNA vaccines. New work by researchers at the VIB-UGent Center for Inflammation Research, Ghent University, and University Hospital Ghent, among ... VIB (the Flanders Institute for Biotechnology) Medical Xpress

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Situation Report

Read more about Repeated COVID vaccinations found to enhance mucosal immunity in the nose against the virus
Log in or register to post comments

RSV: US FDA approves Pfizer's RSV vaccine for older adults at increased risk

Wed, 2024-10-23 09:48 — mike kraft

US FDA approves Pfizer's RSV vaccine for adults at increased risk of the disease The U.S. Food and Drug Administration on Tuesday approved Pfizer's RSV vaccine for the prevention of lower respiratory tract disease caused by RSV in adults aged 18 to 59 at increased risk of the disease. Reuters Reuters

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about RSV: US FDA approves Pfizer's RSV vaccine for older adults at increased risk
Log in or register to post comments

Evaluating this year’s COVID booster as a good match for new variants

Mon, 2024-10-21 09:51 — mike kraft

Is this year’s COVID booster a good match for new variants? Depending on when you last got vaccinated, that COVID-19 shot may no longer be a good match for the variants expected to dominate this fall and winter. amartichoux The Hill

...

While they may not be a perfect match, the latest variants have enough in common with the KP.2 and JN.1 that the boosters should still offer effective cross-protection.

...

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Read more about Evaluating this year’s COVID booster as a good match for new variants
Log in or register to post comments

Explainer: Vaccination side effects and what they indicate

Fri, 2024-10-18 17:40 — mike kraft

What Vaccine Side Effects Really Mean And is it bad not to have side effects after a shot? Jamie Ducharme TIME

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Read more about Explainer: Vaccination side effects and what they indicate
Log in or register to post comments

Only a quarter of US adults concerned about RSV, down from 35% in 2023 --survey

Fri, 2024-10-18 17:06 — mike kraft

Survey: Only a quarter of US adults concerned about RSV, down from 35% in 2023 The disease continues to spread in the Americas, with Ecuador and Guyana recently reporting their first cases. CIDRAP

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Situation Report

Read more about Only a quarter of US adults concerned about RSV, down from 35% in 2023 --survey
Log in or register to post comments

Mpox vaccine rollout in Congo is reported going slower than expected

Fri, 2024-10-18 10:03 — mike kraft

Mpox vaccine rollout in Congo slower than expected, health official says

KIBATI, Democratic Republic of Congo, Oct 18 (Reuters) - Congo needs to do more to raise awareness about mpox and the availability of vaccines, an official with the response team said on Thursday, warning the campaign to distribute the shots would take longer than anticipated

Congo's mpox vaccination campaign launched this month in the hard-hit east.

Country / Region Tags:

Africa

Democratic Republic of the Congo

General Topic Tags: